Autor Título Original / Colaboración Selecciona una opción Original Colaboración Año Selecciona un año2015201620172018201920202021202220232024 Cuartil Selecciona un cuartilD1Q1Q2Q3Q4 Tipo Selecciona un tipo#N/DArticleArtículoBook ChapterBook ReviewClinical TrialCommentaryCorrectionData PaperEditorialEditorial MaterialLetterProceedings PaperReprintReview Revista Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (vol 19, pg 83, 2019) Autores: Canet, LM; Sanchez-Maldonado, JM; Caliz, R; Rodriguez-Ramos, A; Lupianez, CB; Canhao, H; Martinez-Bueno, M; Escudero, A; Segura-Catena, J; Sorensen, SB; Hetland, ML; Soto-Pino, MJ; Ferrer, MA; Garcia, A; Glintborg, B; Filipescu, I; Perez-Pampin, E; Gonzalez-Utrilla, A; Nevot, MAL; Conesa-Zamora, P; den Broeder, A; De Vita, S; Jacobsen, SEH; Collantes-Estevez, E; Quartuccio, L; Canzian, F; Fonseca, JE; Coenen, MJH; Andersen, V; Sainz, J Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study Autores: Campa, D; Martino, A; Macauda, A; Dudzinski, M; Suska, A; Druzd-Sitek, A; Raab, MS; Moreno, V; Huhn, S; Butrym, A; Sainz, J; Szombath, G; Rymko, M; Marques, H; Lesueur, F; Vangsted, AJ; Vogel, U; Kruszewski, M; Subocz, E; Buda, G; Iskierka-Jazdzewska, E; Rios, R; Merz, M; Schottker, B; Mazur, G; Perrial, E; Martinez-Lopez, J; Butterbach, K; Sanz, RG; Goldschmidt, H; Brenner, H; Jamroziak, K; Reis, RM; Kadar, K; Dumontet, C; Watek, M; Haastrup, EK; Helbig, G; Jurczyszyn, A; Jerez, A; Varkonyi, J; Barington, T; Grzasko, N; Zaucha, JM; Andersen, V; Zawirska, D; Canzian, F Feasibility of treatment discontinuation in chronic myeloid leukemia in clinical practice: results from a nationwide series of 236 patients Autores: Hernandez-Boluda, JC; Pereira, A; Pastor-Galan, I; Alvarez-Larran, A; Savchuk, A; Puerta, JM; Sanchez-Pina, JM; Collado, R; Diaz-Gonzalez, A; Angona, A; Sagues, M; Garcia-Gutierrez, V; Boque, C; Osorio, S; Vallansot, R; Palomera, L; Mendizabal, A; Casado, LF; Perez-Encinas, M; Perez-Lopez, R; Ferrer-Marin, F; Sanchez-Guijo, F; Garcia, C; de las Heras, N; Lopez-Lorenzo, JL; Cervantes, F; Steegmann, JL Mechanisms That Contribute to a Profound Reduction of the HIV-1 Reservoir After Allogeneic Stem Cell Transplant Autores: Salgado, M; Kwon, M; Galvez, C; Badiola, J; Nijhuis, M; Bandera, A; Balsalobre, P; Miralles, P; Buno, I; Martinez-Laperche, C; Vilaplana, C; Jurado, M; Clotet, B; Wensing, A; Martinez-Picado, J; Diez-Martin, JL Cost-effectiveness of posaconazole tablets versus fluconazole as prophylaxis for invasive fungal diseases in patients with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation Autores: Grau, S; Camara, R; Jurado, M; Sanz, J; Aragon, B; Gozalbo, I Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients Autores: Macauda, A; Castelli, E; Buda, G; Pelosini, M; Butrym, A; Watek, M; Kruszewski, M; Vangsted, AJ; Rymko, M; Jamroziak, K; Abildgaard, N; Haastrup, EK; Mazur, G; Rios, R; Jurczyszyn, A; Zawirska, D; Dudzinski, M; Razny, M; Dutka, M; Tomczak, W; Suska, A; Druzd-Sitek, A; Marques, H; Petrini, M; Markiewicz, M; Martinez-Lopez, J; Ebbesen, LH; Iskierka-Jazdzewska, E; Sainz, J; Canzian, F; Campa, D Elaboration of Criteria and Indicators to Develop and Evaluate Programs of Healthy Aging in the Workplace. Autores: Mateo Rodríguez I; Daponte Codina A; Bernal Solano M; Sánchez Pérez MJ. < 1 2 … 1.366 1.367 1.368 … 1.504 1.505 >